Literature DB >> 20379280

2008-based national population projections for the United Kingdom and constituent countries.

Emma Wright1.   

Abstract

The 2008-based national population projections, produced by the Office for National Statistics in consultation with the devolved administrations, show the population of the UK rising from 61.4 million in 2008 to 65.6 million in 2018 and 71.6 million by 2033. In the longer-term, the projections suggest that the population will continue rising beyond 2033 for the full length of the projection period. The population will become older with the median age expected to rise from 39.3 years in 2008 to 42.2 years by 2033. Despite the forthcoming changes to state pension age, the number of people of working age for every person of state pensionable age will reduce from 3.23 in 2008 to 2.78 by 2033.List of tables, 93.

Entities:  

Mesh:

Year:  2010        PMID: 20379280     DOI: 10.1057/pt.2010.7

Source DB:  PubMed          Journal:  Popul Trends        ISSN: 0307-4463


  5 in total

1.  Estimating Large Correlation Matrices for International Migration.

Authors:  Jonathan J Azose; Adrian E Raftery
Journal:  Ann Appl Stat       Date:  2018-07-28       Impact factor: 2.083

2.  Bayesian Probabilistic Projection of International Migration.

Authors:  Jonathan J Azose; Adrian E Raftery
Journal:  Demography       Date:  2015-10

3.  Research Exploring Physical Activity in Care Homes (REACH): study protocol for a randomised controlled trial.

Authors:  Anne Forster; Jennifer Airlie; Karen Birch; Robert Cicero; Bonnie Cundill; Alison Ellwood; Mary Godfrey; Liz Graham; John Green; Claire Hulme; Rebecca Lawton; Vicki McLellan; Nicola McMaster; Amanda Farrin
Journal:  Trials       Date:  2017-04-19       Impact factor: 2.279

4.  Falls in hospital and new placement in a nursing home among older people hospitalized with acute illness.

Authors:  David Basic; Tabitha J Hartwell
Journal:  Clin Interv Aging       Date:  2015-10-14       Impact factor: 4.458

5.  Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.

Authors:  Samuel Golpanian; Darcy L DiFede; Marietsy V Pujol; Maureen H Lowery; Silvina Levis-Dusseau; Bradley J Goldstein; Ivonne H Schulman; Bangon Longsomboon; Ariel Wolf; Aisha Khan; Alan W Heldman; Pascal J Goldschmidt-Clermont; Joshua M Hare
Journal:  Oncotarget       Date:  2016-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.